Breast Cancer Chemotherapy-Related Cognitive Dysfunction

Clinical Breast Cancer - Tập 3 - Trang S84-S90 - 2002
Tim A. Ahles1, Andrew J. Saykin2,3
1Department of Psychiatry and Center for Psycho-Oncology Research, Dartmouth-Hitchcock Medical Center, Lebanon, NH
2Department of Psychiatry (Neuropsychology Program), Dartmouth-Hitchcock Medical Center, Lebanon, NH
3New Hampshire Hospital, Concord, NH

Tài liệu tham khảo

Meyers, 2000, Neurocognitive dysfunction in cancer patients, Oncology (Huntingt), 14, 75

Olin, 2001, Cognitive function after systemic therapy for breast cancer, Oncology, 15, 613

1999

Ferrell, 1997, Quality of life among long-term cancer survivors, Oncology (Huntingt), 11, 565

Komaki, 1995, Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation, Int J Radiat Oncol Biol Phys, 33, 179, 10.1016/0360-3016(95)00026-U

Wieneke, 1995, Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer, Psycho-Oncology, 4, 61, 10.1002/pon.2960040108

Ahles, 1996, Psychologic and neuropsychologic impact of autologous bone marrow transplantation, J Clin Oncol, 14, 1457, 10.1200/JCO.1996.14.5.1457

Brezden, 2000, Cognitive function in breast cancer patients receiving adjuvant chemotherapy, J Clin Oncol, 18, 2695, 10.1200/JCO.2000.18.14.2695

Breitbart, 1998, Metabolic disorders and neuropsychiatric symptoms

van Dam, 1998, Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy, J Natl Cancer Inst, 90, 210, 10.1093/jnci/90.3.210

Harder, 2002, Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation, Cancer, 95, 183, 10.1002/cncr.10627

Schagen, 1999, Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma, Cancer, 85, 640, 10.1002/(SICI)1097-0142(19990201)85:3<640::AID-CNCR14>3.0.CO;2-G

Ahles, 2002, Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma, J Clin Oncol, 20, 485, 10.1200/JCO.20.2.485

Ahles, 1998, Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B, J Clin Oncol, 16, 1954, 10.1200/JCO.1998.16.5.1954

Phipps S, Dunavant M, Srivastava DK, et al. Neuropsychological outcome in survivors of pediatric bone marrow transplantation. Paper presented at: Cancer Survivorship: Research Challenges and Opportunities for the New Millennium; March 8-9, 1999; Bethesda, MD.

Syrjala KL, Dikmen S, Roth-Roener S, et al. Prospective longitudinal neuropsychological testing of patients receiving high dose chemotherapy: results and methodological issues. Paper presented at: Cancer Survivorship: Research Challenges and Opportunities for the New Millennium; March 8-9, 1999; Bethesda, MD.

Keime-Guibert, 1998, Neurological complications of radiotherapy and chemotherapy, J Neurol, 245, 695, 10.1007/s004150050271

Tuxen, 1994, Neurotoxicity secondary to antineoplastic drugs, Cancer Treat Rev, 20, 191, 10.1016/0305-7372(94)90027-2

Troy, 2000, Cisplatin-based therapy: a neurological and neuropsychological review, Psychooncology, 9, 29, 10.1002/(SICI)1099-1611(200001/02)9:1<29::AID-PON428>3.0.CO;2-Z

Ahles, 2001, Cognitive effects of standard-dose chemotherapy in patients with cancer, Cancer Invest, 19, 812, 10.1081/CNV-100107743

Bremner, 1995, MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder, Am J Psychiatry, 152, 973, 10.1176/ajp.152.7.973

Bremner, 1998, The effects of stress on memory and the hippocampus throughout the life cycle: implications for childhood development and aging, Dev Psychopathol, 10, 871, 10.1017/S0954579498001916

Fuchs, 2001, Psychosocial stress, glucocorticoids, and structural alterations in the tree shrew hippocampus, Physiol Behav, 73, 285, 10.1016/S0031-9384(01)00497-8

Stemmer, 1994, White matter changes in patients with breast cancer treated with high-dose chemotherapy and autologous bone marrow support, AJNR Am J Neuroradiol, 15, 1267

Brown, 1998, White matter disease induced by high-dose chemotherapy: longitudinal study with MR imaging and proton spectroscopy, AJNR Am J Neuroradiol, 19, 217

Kingma, 2001, Slight cognitive impairment and magnetic resonance imaging abnormalities but normal school levels in children treated for acute lymphoblastic leukemia with chemotherapy only, J Pediatr, 139, 413, 10.1067/mpd.2001.117066

Saykin A, Ahles TA, Schoenfeld JD, et al. Gray matter reduction on voxelbased morphometry in chemotherapy-treated cancer survivors. Paper presented at: Annual Meeting of the International Neuropsychological Society; 2003.

Schagen, 2001, Neurophysiological evaluation of late effects of adjuvant high-dose chemotherapy on cognitive function, J Neurooncol, 51, 159, 10.1023/A:1010635229762

Castro, 1987, A developmental analysis of the learning and short-term memory processes mediating performance in conditional-spatial discrimination problems, Psychobiol, 15, 308, 10.3758/BF03327287

Rudy, 2001, Conjunctive representations, the hippocampus, and contextual fear conditioning, Cogn Affect Behav Neurosci, 1, 66, 10.3758/CABN.1.1.66

Pugh, 1999, Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation, Behav Brain Res, 106, 109, 10.1016/S0166-4328(99)00098-4

Rachal Pugh, 2001, The immune system and memory consolidation: a role for the cytokine IL-1beta, Neurosci Biobehav Rev, 25, 29, 10.1016/S0149-7634(00)00048-8

Lezak, 1995

Mori, 1997, Premorbid brain size as a determinant of reserve capacity against intellectual decline in Alzheimer's disease, Am J Psychiatry, 154, 18, 10.1176/ajp.154.1.18

Stern, 1996, Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection, Arch Neurol, 53, 148, 10.1001/archneur.1996.00550020052015

Cimprich, 1992, Attentional fatigue following breast cancer surgery, Res Nurs Health, 15, 199, 10.1002/nur.4770150306

Cull, 1994, Neurological and cognitive impairment in long-term survivors of small cell lung cancer, Eur J Cancer, 30A, 1067, 10.1016/0959-8049(94)90458-8

Richard, 2001, Genetic susceptibility factors for Alzheimer's disease, Eur J Pharmacol, 412, 1, 10.1016/S0014-2999(00)00903-1

Tardiff, 1997, Preliminary report of a genetic basis for cognitive decline after cardiac operations. The Neurologic Outcome Research Group of the Duke Heart Center, Ann Thorac Surg, 64, 715, 10.1016/S0003-4975(97)00757-1

Newman, 1995, Predictors of cognitive decline after cardiac operation, Ann Thorac Surg, 59, 1326, 10.1016/0003-4975(95)00076-W

Liberman, 2002, Apolipoprotein E epsilon 4 and short-term recovery from predominantly mild brain injury, Neurology, 58, 1038, 10.1212/WNL.58.7.1038

Jordan, 1997, Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing, JAMA, 278, 136, 10.1001/jama.1997.03550020068040

Kutner, 2000, Lower cognitive performance of older football players possessing apolipoprotein E epsilon4, Neurosurgery, 47, 651

Haan, 1999, The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons, JAMA, 282, 40, 10.1001/jama.282.1.40

Sherwin, 1998, Cognitive assessment for postmenopausal women and general assessment of their mental health, Psychopharmacol Bull, 34, 323

Sherwin, 1998, Estrogen and cognitive functioning in women, Proc Soc Exp Biol Med, 217, 17, 10.3181/00379727-217-44200

Kampen, 1994, Estrogen use and verbal memory in healthy postmenopausal women, Bst Gynecol, 78, 991

Ditkoff, 1991, Estrogen improves psychological function in asymptomatic postmenopausal women, Obstet Gynecol, 78, 991

Barrett-Connor, 1993, Estrogen replacement therapy and cognitive function in older women, JAMA, 269, 2637, 10.1001/jama.1993.03500200051032

Sherwin, 1990, Estrogen and cognitive functioning in surgically menopausal women, Ann NY Acad Sci, 592, 474, 10.1111/j.1749-6632.1990.tb30379.x

Yaffe, 2000, Cognitive decline in women in relation to non-protein-bound oestradiol concentrations, Lancet, 356, 708, 10.1016/S0140-6736(00)02628-3

Arpels, 1996, The female brain hypoestrogenic continuum from the premenstrual syndrome to menopause. A hypothesis and review of supporting data, J Reprod Med, 41, 633

Paganini-Hill, 2000, Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen, Breast Cancer Res Treat, 64, 165, 10.1023/A:1006426132338

Yaffe, 2001, Cognitive function in postmenopausal women treated with raloxifene, N Engl J Med, 344, 1207, 10.1056/NEJM200104193441604

Ernst, 2002, The effects of tamoxifen and estrogen on brain metabolism in elderly women, J Natl Cancer Inst, 94, 592, 10.1093/jnci/94.8.592

Winer EP, Hudis C, Burstein HJ, et al. ASCO technology assessment: the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor positive breast cancer: status report 2002. J Clin Oncol. In press.

O'Shaughnessy, 2002, Effects of epoetin alfa on cognitive function, mood, asthenia, and quality of life in women with breast cancer undergoing adjuvant chemotherapy, Clin Breast Cancer, 3, S116, 10.3816/CBC.2002.s.022

Barton, 2002, Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible, Clin Breast Cancer, 3, S121, 10.3816/CBC.2002.s.023

Sohlberg, 1989

Ferguson RJ, Ahles TA. Brief cognitive-behavioral treatment of chemotherapy associated attention and memory complaints among breast cancer survivors: pilot data. Paper presented at: Society of Behavioral Medicine; April 3-6, 2002, Washington, D. C.

Thông tin
Thông tin xuất bản

Clinical Breast Cancer

Tập 3

S84-S90

Thông tin tác giả